Geisinger

December 12, 2020

Patients with COVID-19 and end-stage renal disease were 11 times more likely to be admitted to the hospital than patients without kidney disease.

October 05, 2020

The National Insistutes of Health (NIH) study aims to discover new forms of diabetes, understand what makes them unique, and identify root causes.

September 10, 2020

Data shows low correlation between coronavirus disease (COVID) infection and stroke.

September 04, 2020

Award presented at virtual Telehealth Innovation Forum.

August 26, 2020

New mobile dental health unit provides dental exams and preventive services at no cost.

August 21, 2020

Results of observational study published in Genetics in Medicine.

July 14, 2020

The study measures satisfaction among members of 149 health plans in 21 regions of the United States.

June 21, 2019

Geisinger announced that its Board of Directors has appointed Jaewon Ryu, MD, JD, as president and chief executive officer. Dr. Ryu, who has served as interim president and CEO since November 2018 and executive vice president and chief medical officer since September 2016, becomes the seventh chief executive officer in Geisinger’s 104-year history. He succeeds David T. Feinberg, M.D., MBA, who left Geisinger earlier this year to assume a leadership role at Google.

March 01, 2019

Geisinger Home Health and Hospice, LHC Group, and AtlantiCare Home Health and Hospice have announced a joint venture to enhance home health and hospice services.

February 13, 2019

Hoping to mitigate the impact of opioid use during pregnancy, Geisinger's Steele Institute for Health Innovation is launching Free2BMom, a new care delivery program to help mothers and their newborns through recovery with social support and other services.